Results 71 to 80 of about 1,518,675 (340)
Journal of Community Service and Empowerment, 2023 The COVID-19 pandemic in Indonesia has resulted in high morbidity and mortality from COVID-19. Providing COVID-19 vaccination is one step to minimize the impact of COVID-19.
Ekorini Listiowati +6 more
doaj +1 more source
Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey
Journal of Multidisciplinary Healthcare, 2020 Background Vaccine hesitancy is a potential threat to global public health. Since there is an unprecedented global effort to develop a vaccine against the COVID-19 pandemic, much less is known about its acceptance in the community.
M. Al-Mohaithef, B. Padhi
semanticscholar +1 more source
Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021
Nature Communications, 2022 The COVID-19 pandemic continues to impact daily life, including health system operations, despite the availability of vaccines that are effective in greatly reducing the risks of death and severe disease.
J. Lazarus +8 more
semanticscholar +1 more source
Safety of COVID‐19 vaccines [PDF]
Journal of Medical Virology, 2021 AbstractThis study is aimed to identify the adverse effects associated with three types of coronavirus disease 2019 vaccines. Approximately 1736 individuals agreed to participate in this study. The participants involved in the study were individuals who had received the first dose or full course (two doses) of the vaccine at least 30 days before the ...
Qutaiba A. Al Khames Aga +9 more
openaire +2 more sources
Journal of Primary Care & Community Health, 2021 Objectives: Arkansas COVID-19 vaccine uptake has been lower than the national average. This study examined associations between sociodemographic factors and COVID-19 vaccine hesitancy, fear of infection, and protection self-efficacy.
Pearl A. McElfish +5 more
doaj +1 more source
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial
Science, 2021 Description Antibody levels predict vaccine efficacy Symptomatic COVID-19 infection can be prevented by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines.
P. Gilbert +39 more
semanticscholar +1 more source
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
Blood, 2021 Patients with chronic lymphocytic leukemia (CLL) have been previously shown to have poor responses to antibacterial and antiviral vaccines. In a Plenary Paper that is also this month’s CME article, Herishanu and colleagues discuss the outcome of ...
Y. Herishanu +12 more
semanticscholar +1 more source
COVID-19 vaccines and myocarditis
Archives of Cardiovascular Diseases, 2021 No abstract ...
Kerneis, Mathieu +2 more
openaire +3 more sources
The Lancet, 2021 Background Many countries are experiencing a resurgence of COVID-19, driven predominantly by the delta (B.1.617.2) variant of SARS-CoV-2. In response, these countries are considering the administration of a third dose of mRNA COVID-19 vaccine as a ...
N. Barda +7 more
semanticscholar +1 more source
Timelines of COVID-19 Vaccines
Current Medicine Research and Practice, 2020 World Health Organisation discussed the “Top Threats to Human Health in 2019,” and developed a strategic plan to meet the challenges. Among the communicable diseases. Emerging and Re-emerging viral pathogens causing Global Pandemic with devastating results were emphasised.
openaire +3 more sources